Telegram Group & Telegram Channel
Since the announcement of a single Pythia experiment, Neiry’s following has exploded—but in truth, Neiry is a vast, international group of companies driving innovation across brain–computer interfaces, neurophysiology, and neurology.

Our mission is to guide humanity into its next evolutionary stage through neurotechnology—directly integrating brains with computers to unlock unprecedented human–machine synergy. This leap will enhance human performance in every field that relies on digital interaction.

No one loves neurotechnology more than we do: Neiry offers the world’s broadest array of BCI segments:

-Medical neurology & neurophysiology (invasive and non-invasive)
-Mental well-being solutions
-Neuromarketing & “brain data” commerce
-API & SDK platforms for diverse industries (from professional services to poker and education)
-Agricultural applications
-Pet care and industrial canine assistance
-“Superhuman” enhancements (augmented vision, on-demand motivation, new qualia, extra limbs, and more)

Beyond Pythia, Neiry supports over 50 products—most non-invasive, requiring no trepanation. For example, MindTracker is a consumer BCI device for mental health that empowers users to boost productivity and manage stress; it’s sold by the thousands across 33 countries. Every Neiry device features a robust API/SDK, enabling one piece of hardware to power countless applications—whether it’s our own MindTracker or third-party titles like Raise It (https://raiseit.ru/eng/) for poker players. Identical devices. Infinite possibilities.



tg-me.com/ratpythia/97
Create:
Last Update:

Since the announcement of a single Pythia experiment, Neiry’s following has exploded—but in truth, Neiry is a vast, international group of companies driving innovation across brain–computer interfaces, neurophysiology, and neurology.

Our mission is to guide humanity into its next evolutionary stage through neurotechnology—directly integrating brains with computers to unlock unprecedented human–machine synergy. This leap will enhance human performance in every field that relies on digital interaction.

No one loves neurotechnology more than we do: Neiry offers the world’s broadest array of BCI segments:

-Medical neurology & neurophysiology (invasive and non-invasive)
-Mental well-being solutions
-Neuromarketing & “brain data” commerce
-API & SDK platforms for diverse industries (from professional services to poker and education)
-Agricultural applications
-Pet care and industrial canine assistance
-“Superhuman” enhancements (augmented vision, on-demand motivation, new qualia, extra limbs, and more)

Beyond Pythia, Neiry supports over 50 products—most non-invasive, requiring no trepanation. For example, MindTracker is a consumer BCI device for mental health that empowers users to boost productivity and manage stress; it’s sold by the thousands across 33 countries. Every Neiry device features a robust API/SDK, enabling one piece of hardware to power countless applications—whether it’s our own MindTracker or third-party titles like Raise It (https://raiseit.ru/eng/) for poker players. Identical devices. Infinite possibilities.

BY Pythia


Warning: Undefined variable $i in /var/www/tg-me/post.php on line 283

Share with your friend now:
tg-me.com/ratpythia/97

View MORE
Open in Telegram


Pythia Telegram | DID YOU KNOW?

Date: |

That growth environment will include rising inflation and interest rates. Those upward shifts naturally accompany healthy growth periods as the demand for resources, products and services rise. Importantly, the Federal Reserve has laid out the rationale for not interfering with that natural growth transition.It's not exactly a fad, but there is a widespread willingness to pay up for a growth story. Classic fundamental analysis takes a back seat. Even negative earnings are ignored. In fact, positive earnings seem to be a limiting measure, producing the question, "Is that all you've got?" The preference is a vision of untold riches when the exciting story plays out as expected.

Spiking bond yields driving sharp losses in tech stocks

A spike in interest rates since the start of the year has accelerated a rotation out of high-growth technology stocks and into value stocks poised to benefit from a reopening of the economy. The Nasdaq has fallen more than 10% over the past month as the Dow has soared to record highs, with a spike in the 10-year US Treasury yield acting as the main catalyst. It recently surged to a cycle high of more than 1.60% after starting the year below 1%. But according to Jim Paulsen, the Leuthold Group's chief investment strategist, rising interest rates do not represent a long-term threat to the stock market. Paulsen expects the 10-year yield to cross 2% by the end of the year. A spike in interest rates and its impact on the stock market depends on the economic backdrop, according to Paulsen. Rising interest rates amid a strengthening economy "may prove no challenge at all for stocks," Paulsen said.

Pythia from ar


Telegram Pythia
FROM USA